Do In Vitro Susceptibility Data Predict the Microbiologic Response to Amphotericin B? Results of a Prospective Study of Patients with Candida Fungemia

Nguyen, M. Hong, Clancy, Cornelius J., Yu, Victor L., Yu, Yue C., Morris, Arthur J., Snydman, David R., Sutton, Deanna A., Rinaldi, Michael G.·1998·The Journal of Infectious Diseases
DOI 10.1086/514193

Cited by (219)

Items 101–200 of 219

  1. Interactions of Yeasts, Moulds, and Antifungal Agents
    Gerri S. Hall · 2011 · Humana Press eBooks
  2. Clinical Manifestations and Molecular Epidemiology of Late Recurrent Candidemia, and Implications for Management
    Cornelius Joseph Clancy, Francesco Barchiesi, Lorenzo DiFrancesco, Arthur J. Morris, David R. Snydman, Victor L. Yu, Giorgio Scalise, M. Hong Nguyen · 2000 · European Journal of Clinical Microbiology & Infectious Diseases
  3. Correlation between In Vitro Activity of Posaconazole and In Vivo Efficacy against Rhizopus oryzae Infection in Mice
    M. Mar Rodríguez, Francisco Javier Pastor, Deanna A. Sutton, Enrique Calvo, Annette W. Fothergill, Valentina Salas, Michael G. Rinaldi, Josep Guarro · 2010 · Antimicrobial Agents and Chemotherapy
  4. Antifungal Drug Susceptibility Profile of Pichia anomala Isolates from Patients Presenting with Nosocomial Fungemia
    Vânia Lúcia Ribeiro da Matta, Márcia de Souza Carvalho Melhem, Arnaldo Lopes Colombo, Maria Luíza Moretti, L Rodero, Gisele Madeira Duboc de Almeida, Marilena dos Anjos Martins, Sílvia Figueiredo Costa, Maria Beatriz Souza Dias, Márcio Nucci et al. · 2007 · Antimicrobial Agents and Chemotherapy
  5. In Vitro Susceptibility Tests in the Context of Antifungal Resistance: Beyond Minimum Inhibitory Concentration in Candida spp.
    Iacopo Franconi, Antonella Lupetti · 2023 · Journal of Fungi
  6. Susceptibility profile of 200 bloodstream isolates of Candida spp. collected from Brazilian tertiary care hospitals
    Arnaldo Lopes Colombo, Zelinda Maria Bartolomei Nakagawa, Fábio Valdetaro, Maria Luíza Moretti Branchini, Elisa Junko Ura Kusano, Márcio Nucci · 2003 · Medical Mycology
  7. Utility of mould susceptibility testing
    Ana Espinel‐Ingroff · 2003 · Current Opinion in Infectious Diseases
  8. Fluconazole exposure rather than clonal spreading is correlated with the emergence of Candida glabrata with cross‐resistance to triazole antifungal agents
    Tun‐Chieh Chen, Yen‐Hsu Chen, Yee‐Chun Chen, Po‐Liang Lu · 2012 · The Kaohsiung Journal of Medical Sciences
  9. In Vitro Susceptibilities of Invasive Isolates of Candida Species: Rapid Increase in Rates of Fluconazole Susceptible-Dose Dependent Candida glabrata Isolates
    Sheng‐Yuan Ruan, Chenchen Chu, Po‐Ren Hsueh · 2008 · Antimicrobial Agents and Chemotherapy
  10. The increased role of non-albicans species in candidaemia: results from a 3-year surveillance study
    Thean Yen Tan, Ai Ling Tan, Nancy Wen Sim Tee, Lily Siew Yong Ng, Chloe W. J. Chee · 2009 · Mycoses
  11. Potential fungicidal effect of voriconazole against Candida spp.
    M. Carmen Rubio, Inmaculada Ramírez de Ocáriz, Joaquina Gil, Rafael Benito, Antonio Rezusta · 2005 · International Journal of Antimicrobial Agents
  12. Candidemia in the in-patient setting: treatment options and economics
    Joshua J Gagne, Neil I. Goldfarb · 2007 · Expert Opinion on Pharmacotherapy
  13. Clinical and epidemiological aspects of Candidemia in eight medical centers in the state of Parana, Brazil: Parana Candidemia Network
    Carla Sakuma de Oliveira, Arnaldo Lopes Colombo, Elaine Cristina Francisco, Bernardo de Lima, Rinaldo Ferreira Gandra, Mariza Cristina Preifz de Carvalho, Cláudia Maria Dantas de Maio Carrilho, Renan Pontes Petinelli, Marsilene Pelisson, César Helbel et al. · 2020 · The Brazilian Journal of Infectious Diseases
  14. p-Coumaric acid loaded into liquid crystalline systems as a novel strategy to the treatment of vulvovaginal candidiasis
    Paula Scanavez Ferreira, Francesca Damiani Victorelli, Camila Fernanda Rodero, Giovanna Capaldi Fortunato, Victor Hugo Sousa Araújo, Bruno Fonseca‐Santos, Taís Maria Bauab, Patrick Van Dijck, Marlus Chorilli · 2021 · International Journal of Pharmaceutics
  15. The Evolving Role of Antifungal Susceptibility Testing
    Gregory A. Eschenauer, Peggy L. Carver · 2013 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
  16. Amphotericin-B Colloidal Dispersion
    Rex N. Brogden, Karen L. Goa, Allan J. Coukell · 1998 · Drugs
  17. Catheter-related fungemia caused by Candida intermedia
    Sheng‐Yuan Ruan, Jung‐Yien Chien, Yi-Chung Hou, Po‐Ren Hsueh · 2009 · International Journal of Infectious Diseases
  18. Genetically recombinant antibodies: new therapeutics against candidiasis
    J. Burnie, Ruth Matthews · 2004 · Expert Opinion on Biological Therapy
  19. Amphotericin B: Polyene Resistance Mechanisms
    Elizabeth M. O’Shaughnessy, Caron A. Lyman, Thomas J. Walsh · 2009 · Humana Press eBooks
  20. Health care-associated invasive Candida infections in children
    Bahaettin Öncü, Nurşen Belet, Ahmet Naci Emecen, Asuman Bırıncı · 2019 · Medical Mycology
  21. Antifungal susceptibility of bloodstream yeasts isolated at a public children’s hospital in Brazil: comparison of the Etest® and the AFST–EUCAST microdilution method
    Flavia Emi Matsumoto, Amanda Latércia Tranches Dias, Márcia de Souza Carvalho Melhem, Maria Walderez Szeszs, Marcos Ereno Auler, Luciana da Silva Ruiz, Eriques Gonçalves Silva, Rinaldo Ferreira Gandra, Claudete Rodrigues Paula · 2007 · Canadian Journal of Microbiology
  22. Candida glabrata fungaemia in a tertiary centre in Taiwan: antifungal susceptibility and outcomes
    Sheng‐Yuan Ruan, Yu‐Tsung Huang, Chen-Chen Chu, Chong‐Jen Yu, Po‐Ren Hsueh · 2009 · International Journal of Antimicrobial Agents
  23. Emergence of resistant Candida in neutropenic patients
    Márcio Nucci, Arnaldo Lopes Colombo · 2002 · The Brazilian Journal of Infectious Diseases
  24. Antifungal pharmacokinetics and pharmacodynamics: understanding the implications for antifungal drug resistance
    David R. Andes · 2004 · Drug Resistance Updates
  25. Impact of endpoint definition on the outcome of antifungal susceptibility tests with Candida species: 24- versus 48-h incubation and 50 versus 80% reduction in growth
    G. St‐Germain · 2001 · Mycoses
  26. In vitro antifungal susceptibility testing of Candida blood isolates and evaluation of the E-test method.
    Jang‐Jih Lu, Shih-Yi Lee, Tzong‐Shi Chiueh · 2004 · PubMed
  27. Molecular identification and antifungal susceptibility profiles of Candida parapsilosis complex species isolated from culture collection of clinical samples
    Fábio Silvestre Ataídes, Carolina Rodrigues Costa, Lúcia Kioko Hasimoto e Souza, Orionalda de Fátima Lisboa Fernandes, Rosália Santos Amorim Jesuíno, Maria do Rosário Rodrigues Silva · 2015 · Revista da Sociedade Brasileira de Medicina Tropical
  28. Antifungal susceptibility testing following the CLSI M27 document, along with the measurement of MFC/MIC ratio, could be the optimal approach to detect amphotericin B resistance in Clavispora ( Candida ) lusitaniae . Susceptibility patterns of contemporary isolates of this species
    Natalia Sasoni, Beatriz Caracciolo, Matías Sebastián Cabeza, Soledad Pinto Gamarra, Susana Carnovale, Guillermo García‐Effrón · 2023 · Antimicrobial Agents and Chemotherapy
  29. Identification and antifungal susceptibility of Candida species isolated from the urine of patients in a university hospital in Brazil
    Gláucia Moreira Espíndola Lima, Maína de Oliveira Nunes, Marilene Rodrigues Chang, Rosianne Assis de Sousa Tsujisaki, Joslaine de Oliveira Nunes, Cleison Ledesma Taira, Danilo Yamamoto Thomaz, Gilda Maria Bárbaro Del Negro, Rinaldo Pôncio Mendes, Anamaria Mello Miranda Paniago · 2017 · Revista do Instituto de Medicina Tropical de São Paulo
  30. FREQUENCY OF Candida SPECIES IN A TERTIARY CARE HOSPITAL IN TRIANGULO MINEIRO, MINAS GERAIS STATE, BRAZIL
    Ralciane de Paula Menezes, Joseane Cristina Ferreira, Walkíria Machado de Sá, Tomaz de Aquino Moreira, Lucivânia Duarte Silva Malvino, Lúcio Borges de Araújo, Denise Von Dolingër de Brito Röder, Mário Paulo Amante Penatti, Regina Célia Cândido, Reginaldo dos Santos Pedroso · 2015 · Revista do Instituto de Medicina Tropical de São Paulo
  31. Effects of amphotericin B on Aspergillus flavus clinical isolates with variable susceptibilities to the polyene in an experimental model of systemic aspergillosis
    Francesco Barchiesi, Elisabetta Spreghini, Maurizio Sanguinetti, D. Giannini, Esther Manso, Pamela Castelli, Corrado Girmenia · 2013 · Journal of Antimicrobial Chemotherapy
  32. Antifungal Susceptibility Testing
    Annette W. Fothergill, Michael G. Rinaldi, Deanna A. Sutton · 2006 · Infectious Disease Clinics of North America
  33. Virulence Factors and Antifungal Susceptibility in Candida Species Isolated from Dermatomycosis Patients
    Victor Galvão Mello, Heloisa Escudeiro, Ana Carolina Villas Bôas Weckwerth, Maria Izilda Andrade, Ana Elisa Fusaro, Eloise Brasil de Moraes, Luciana da Silva Ruiz, Ida Maria Foschiani Dias Baptista · 2020 · Mycopathologia
  34. Tolerance to amphotericin B in clinical isolates of Candida tropicalis
    Francesco Barchiesi, Monia Maracci, Isabella Baldassarri, Elisabetta Spreghini, Daniele Giannini, Giorgio Scalise · 2004 · Diagnostic Microbiology and Infectious Disease
  35. Emerging issues in nosocomial fungal infections
    Cristiana M. Toscano, William Robert Jarvis · 1999 · Current Infectious Disease Reports
  36. Species distribution andin vitroantifungal susceptibility of clinicalCandidaisolates from a university hospital in Turkey over a 5-year period
    Nuri̇ Kiraz, Yasemin Öz · 2010 · Medical Mycology
  37. Candidemia-induced pediatric sepsis and its association with free radicals, nitric oxide, and cytokine level in host
    Dharmendra Kumar, Abhai Kumar, Smıta Sıngh, Ragini Tilak · 2014 · Journal of Critical Care
  38. Experimental Models in Predicting Topical Antifungal Efficacy: Practical Aspects and Challenges
    Juan Lai, Howard I. Maïbach · 2009 · Skin Pharmacology and Physiology
  39. Alternatives to amphotericin B for Candida rugosa infection
    S. Hernandez · 2004 · Journal of Antimicrobial Chemotherapy
  40. Detection of Resistance to Amphotericin B in Candida Isolates by Using Iso-Sensitest Broth
    Manuel Cuenca‐Estrella, Teresa M. Dı́az-Guerra, Emilia Mellado, Juan L. Rodrı́guez-Tudela · 2001 · Antimicrobial Agents and Chemotherapy
  41. Update on Clinical Antifungal Susceptibility Testing for Candida Species
    Russell Edward Lewis, Michael E. Klepser, Michael A. Pfaller · 1998 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
  42. Clinical applicability of antifungal susceptibility testing on non-Candida albicans species in hospitalized patients
    Annie Wong-Beringera, Janet F. Hindler, Lilliana Brankovic, Lisa Muehlbauer, Lynn Steele‐Moore · 2001 · Diagnostic Microbiology and Infectious Disease
  43. Antifungal susceptibility patterns of yeast isolates causing bloodstream infections
    Francesco Barchiesi · 2003 · Journal of Antimicrobial Chemotherapy
  44. Survey of amphotericin B susceptibility of Candida clinical isolates determined by Etest.
    Yu-Shin Chiu, Shan‐Chwen Chang, Po‐Ren Hsueh, Jiun‐Ling Wang, Hsin‐Yun Sun, Yee‐Chun Chen · 2006 · PubMed
  45. Risk Factors for Mortality in Colombian Patients with Candidemia
    Jorge Alberto Cortés, Anita Montañez, Ana María Carreño-Gutiérrez, Patricia Reyes, Carlos Gómez, Angela Pescador, Beatríz Ariza, Fernando Rosso · 2021 · Journal of Fungi
  46. Species Distribution andin VitroSusceptibility ofCandidaBloodstream Isolates to Six New and Current Antifungal Agents in a Turkish Tertiary Care Military Hospital, Recovered Through 2001 and 2006
    Mehmet Ali Saraçlı, Ramazan Gümral, Hanefi Cem Gül, A. Gönlüm, Ş. T. Yıldıran · 2009 · Military Medicine
  47. In vitro activity of terbinafine against Indian clinical isolates of Candida albicans and non-albicans using a macrodilution method
    Shubha Garg, Jaishree Naidu, Shri Singh, Shesh Rao Nawange, N. Jharia, M. Saxena · 2006 · Journal de Mycologie Médicale
  48. Amphotericin B: Polyene Resistance Mechanisms
    Matthew William McCarthy, Elizabeth M. O’Shaughnessy, Thomas J. Walsh · 2017 · Springer eBooks
  49. In vitro activity of 6 antifungal agents on candida species isolated as causative agents from vaginal and other clinical specimens
    Mohamed S. Ellabib, I A ElJariny · 2001 · Saudi Medical Journal
  50. Utility of Antifungal Susceptibility Testing and Clinical Correlations
    Daniel J. Diekema, Michael A. Pfaller · 2011 · Humana Press eBooks
  51. Successful Treatment of Pulmonary Blastomycosis with Continuously Infused Amphotericin B Deoxycholate After Failure with Liposomal Amphotericin B
    Robert E. Ariano, Bradley R. Mitchelmore, Philippe R. S. Lagacé-Wiens, Sheryl A Zelenitsky · 2013 · Annals of Pharmacotherapy
  52. Effect of Medium Composition on Static and Cidal Activity of Amphotericin B, Itraconazole, Voriconazole, Posaconazole and Terbinafine AgainstAspergillus fumigatus:A Multicenter Study
    Anna Maria Tortorano, Éric Dannaoui, Joseph Meletiadis, M. Mallié, M.A. Viviani, M. A. Piens, Anna Lisa Rigoni, J.-M. Bastide, R. Grillot, Ebga Network · 2002 · Journal of Chemotherapy
  53. Characterization of Candida spp. isolated from vaginal fluid: identification, antifungal susceptibility, and virulence profile
    Kelly Ishida, Mirian Ueda-Yamaguchi, Sueli Fumie Yamada‐Ogatta, Tânia Ueda‐Nakamura, Terezinha Inez Estivalet Svidzinski, Celso Vataru Nakamura · 2013 · Acta Scientiarum Health Sciences
  54. Clinical relevance of fungal susceptibility testing and antifungal resistance
    Ana Espinel‐Ingroff · 2000 · Clinical Microbiology Newsletter
  55. In Vitro Amphotericin B Susceptibility of Korean Bloodstream Yeast Isolates Assessed by the CLSI Broth Microdilution Method, Etest, and Minimum Fungicidal Concentration Test
    Ji Young Park, Jong Hee Shin, Young Uh, Eui Chong Kim, Seung‐Jung Kee, Soo Hyun Kim, Myung‐Geun Shin, Soon‐Pal Suh, Dong Wook Ryang · 2008 · Annals of Laboratory Medicine
  56. Susceptibility Test Methods: Yeasts and Filamentous Fungi
    Elizabeth M. Johnson, Ana Victoria Espinel-Ingroff, Michael A. Pfaller · 2011
  57. Trends in fungaemia and antifungal susceptibility in the Netherlands.
    Frans M. Verduyn Lunel, Johannes G.M. Koeleman, Lodewijk Spanjaard, Christina M. J. E. Vandenbroucke‐Grauls, Charlotte Schultz, Henri Alexander Verbrugh, G Vos, Annet Troelstra, Ellen M. Mascini, Paul E. Verweij et al. · 2006 · PubMed
  58. Should Etest MICs for Yeasts Be Categorized by Reference (BPs/ECVs) or by Etest (ECVs) Cutoffs as Determinants of Emerging Resistance?
    Ana Espinel‐Ingroff, Éric Dannaoui · 2020 · Current Fungal Infection Reports
  59. Susceptibility testing of fungi - current status and open questions
    Michael Seibold, Kathrin Tintelnot · 2003 · Birkhäuser Basel eBooks
  60. Comparative evaluation of the antifungal susceptibility of Candida isolates from blood specimens: results of a study in a tertiary care hospital in Bursa, Turkey
    Canan Evci, Beyza Ener, Güher Göral, Sevim Akçağlar · 2010 · TURKISH JOURNAL OF MEDICAL SCIENCES
  61. Perfil epidemiológico y patrón de sensibilidad de aislamientos causantes de infección fúngica invasora frente a aislamientos fúngicos de colonización en pacientes críticos no neutropénicos
    Ricardo Serrano, Adelina Gimeno, Lidia Plumed, Javier Pemán, Bernabé Álvarez, Joaquín Plazas, Juan Caturla · 2012 · Revista Iberoamericana de Micología
  62. Antifungal and Antiviral Therapy
    Luis Ostrosky‐Zeichner, John H. Rex · 2008 · Elsevier eBooks
  63. Recent changes in candidemia trends in a tertiary hospital (2011–2018)
    Ana Isabel Piqueras, Thomas T. Rubio, Eva María López Medina, Ana Gimeno, Vicent Modesto, Emilia Cantón, Javier Pemán · 2020 · Revista Iberoamericana de Micología
  64. The Role of Resistance in Candida Infections: Epidemiology and Treatment
    Jack D. Sobel, Robert A. Akins · 2017 · Springer eBooks
  65. Efficacy of amphotericin B and flucytosine against fluconazole-resistant Candida inconspicua clinical isolates
    László Majoros, Gábor Kardos, P. Feiszt, B. Szabó · 2005 · Journal of Antimicrobial Chemotherapy
  66. ¿Ha servido para algo una década estandarizando las pruebas de sensibilidad a los antifúngicos?
    Juan Luis Rodríguez Tudela, Manuel Cuenca Estrella · 2002 · Enfermedades Infecciosas y Microbiología Clínica
  67. Comparison between two culture media for in vitro evaluation of antifungal susceptibility of the Sporothrix schenckii complex
    Cheila Denise Ottonelli Stopiglia, Daiane Péres Marchese, Daiane Heidrich, Júlia Medeiros Sorrentino, Fabiane Jamono Vieira, Maria Lúcia Scroferneker · 2012 · Anais Brasileiros de Dermatologia
  68. Antifungal Susceptibility Methods and Their Potential Clinical Relevance
    Ana Espinel‐Ingroff · 2002 · Laboratory Medicine
  69. Is there in vivo–in vitro correlation between antifungal susceptibility, species of Candida spp. and clinical outcome?
    Vladimir Krcmery · 2000 · International Journal of Antimicrobial Agents
  70. Antifungal Chemotherapeutics
    Vladimir Krcmery · 2005 · Medical Principles and Practice
  71. Antifungal Agents and Antifungal Susceptibility Testing
    Sanjay G. Revankar, John R. Graybill, Thomas F. Patterson · 2010 · Wiley eBooks
  72. Impact of host factors on susceptibility to antifungal agents
    Balbina J. Plotkin, Monika I. Konaklieva · 2022 · ADMET & DMPK
  73. Killing Activity of Micafungin Against Candida albicans, C. dubliniensis and Candida africana in the Presence of Human Serum
    Renátó Kovács, Qasem Saleh, Aliz Bozó, Zoltán Tóth, Rudolf Gesztelyi, Tamás Kardos, Gábor Kardos, István Takács, László Majoros · 2017 · Mycopathologia
  74. Reavaliação da suscetibilidade de Candida à anfotericina B: estudo comparativo com isolados de três hospitais do estado do Rio Grande do Sul
    Everton Boff, Paulo Guilherme Markus Lopes, Tatiana Borba Spader, Liliane Alves Scheid, Érico Silva Loreto, Nara Lúcia Frasson Dal Forno, Valério Rodrigues Aquino, Luiz Carlos Severo, Jânio Morais Santúrio, Sydney Hartz Alves · 2008 · Revista da Sociedade Brasileira de Medicina Tropical
  75. Susceptibility of 57 Bloodstream and Urinary Isolates of Candida Species from a Single Children’s University Hospital to 6 Antifungals
    Juraj Hanzen, L Pevalová, M Benedeková, Gabriela Kovacicova, Adriana Ondrusova, Maria Huttova, Vladimir Krcmery · 2002 · Chemotherapy
  76. Head-to-Head Comparison of Etest, MICRONAUT-AM EUCAST and Reference Broth Microdilution-Based CLSI Results for Candida kefyr Antifungal Susceptibility Testing: Implications for Detection of Reduced Susceptibility to Amphotericin B
    Mohammad Asadzadeh, Suhail Ahmad, Jacques F. G. M. Meis, Josie E. Parker, Wadha Ahmed Alfouzan · 2025 · Journal of Fungi
  77. Méthodologie d’évaluation de la sensibilité in vitro aux antifongiques
    Éric Dannaoui · 2006 · Therapies
  78. Destruction of Isolates from the Pittsburgh Veterans Affairs Laboratory
    David R. Snydman, Elias J. Anaissie, George A. Sarosi · 2008 · Clinical Infectious Diseases
  79. The Role of Resistance in Candida Infections: Epidemiology and Treatment
    Jack D. Sobel, Robert A. Akins · 2009 · Humana Press eBooks
  80. Fungal Drug Resistance Assays
    Sevtap Arıkan, John H. Rex · 2009 · Humana Press eBooks
  81. Antifungal Therapy for Invasive Fungal Infections
    Hamid Badali, Sadegh Khodavaisy, Mehrnaz Mohammad Davoudi, E Biranvand, Masoud Mardani · 2014 · Majallah-i dānishgāh-i ̒ulūm-i pizishkī-i Māzandarān/Journal of Mazandaran University of Medical Sciences
  82. Glucan Synthase Inhibitors
    Tawanda Gumbo, Fumiaki Ikeda, Arnold Louie · 2007 · Infectious disease and therapy
  83. Oral colonization by Candida spp. in liver transplant patients: Molecular identification and antifungal susceptibilityOral colonization by Candida spp. in liver transplant
    Clarice Elvira Saggin Sabadin, Soraia Lopes Lima, Olga Fischmamm Gompertz, Gilglécia Novaes Pereira Santana, Analy Salles de Azevedo Melo, Lilian Rigo, Daniel Archimedes da Matta, Dulce Aparecida Barbosa · 2020 · Medical Mycology
  84. Fungal Drug Resistance Assays
    Sevtap Arıkan-Akdağlı, John H. Rex · 2017 · Springer eBooks
  85. Susceptibility Testing Agents of Subcutaneous Mycoses (Sporotrichosis and Chromoblastomycosis)
    Rogelio de J. Treviño‐Rangel, Gloria María González · 2015 · Current Fungal Infection Reports
  86. Relationship Between Susceptibility of Candida spp. Isolates to Amphotericin B and Death or Survival of Patients with Candidemia Episodes
    Sydney Hartz Alves, Everton Boff, Patrícia Pozzatti, Liliane Alves Scheid, Érico Silva Loreto, Loiva T. Ottoneli Oliveira, Valério Rodrigues Aquino, Luiz Carlos Severo, Jânio Morais Santúrio · 2008 · Mycopathologia
  87. Antifungal Agents Pharmacokinetics and Pharmacodynamics of Amphotericin B
    David R. Andes · 2007 · Infectious disease and therapy
  88. Evaluación del desempeño diagnóstico del medio de difusión en agar Etest® para el estudio de sensibilidad a los antifúngicos
    Raquel Nancy Ballesté, Zaida Arteta, Ana Barloco, Cristina Mier, Nora Fernández, Nélida Mousqués, Beatriz Xavier, Cabrera, María José, Ana Combol, E. Gezuele · 2006 · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
  89. Actividad in vitro de las equinocandinas ¿Cómo debe evaluarse?
    Francisco Pastor, Josep Guarro · 2005 · Revista Iberoamericana de Micología
  90. Resistance to Antifungal Agents
    Sevtap Arıkan, John H. Rex · 2010 · Wiley eBooks
  91. Oral candidiasis in liver transplant patients: species identification and antifungal susceptibility profile
    Clarice Elvira Saggin Sabadin, Daniel Archimedes da Matta, Lísia Hoppe, Fernanda Aparecida Vieira Fernandes, Analy Salles de Azevedo Melo, Lilian Rigo, Dulce Aparecida Barbosa · 2024 · Einstein (São Paulo)
  92. Epidemiology of Bloodstream Candida spp. Infections Observed During a Surveillance Study Conducted in Spain
    R Cisterna, Guillermo Ezpeleta, O. Teller · 2012 · InTech eBooks
  93. Antifongigramme: techniques et interprétation
    André Paugam · 2005 · Bio Tribune Magazine
  94. Evaluación económica de antimicóticos en pacientes no neutropénicos con candidiasis invasiva en México
    I Contreras-Hernández, Joaquín Federico Mould-Quevedo, Jorge L. Zendejas-Villanueva, Joaquín Antonio Guzmán Sánchez, Juan Manuel Mejía‐Aranguré, Juan Garduño‐Espinosa · 2011 · PharmacoEconomics Spanish Research Articles
  95. Resistant virulent Candida species colonizing preterm neonates and in vitro promising prospect of chlorhexidine gluconate
    E. Wali Iman, H Bassyouni Rasha, Ahmed El Seidi Eman, E Amira, Ahmed Abdel Razek Abdel Rahman, Abdel Salam Amina, Fouad Reem · 2013 · African Journal of Microbiology Research
  96. Susceptibilidade antifúngica, produção de biofilme e caracterização do gene ALS3 em isolados de Candida albicans e não-albicans do hospital das clínicas, UNESP, Botucatu
    Ariane Cristina Mendes de Oliveira Bruder Nascimento · 2009 · Aleph UCLA Undergraduate Research Journal for the Humanities and Social Sciences
  97. Bloodstream Yeast Species and In Vitro Antifungal Susceptibility Profiles
    2021 · Cyprus Journal of Medical Sciences
  98. Antifungal Agents
    Gerri S. Hall, Jennifer Sekeres, Elizabeth A. Neuner, James O. Hall · 2011 · Humana Press eBooks
  99. Colonisation of acrylic denture fitting surfaces by Candida species
    Nicholas James Knight · 2014 · Otago University Research Archive (University of Otago)
  100. Management of Resistant Candida Infections
    Sanya Clements, Christopher C. Kibbler · 2004 · Humana Press eBooks